Utilizing multiple technologies, today’s hematology analyzers provide numerous capabilities and volume accommodations, which explains why labs rate these systems with high satisfaction. As hematology analyzers and related instrumentation enable the core functions of most clinical labs, their growth in sophistication and automation should bolster acquisitions in the years to come.

Over half of all labs are planning to acquire new hematology instrumentation in the near future.

Laboratories seeking to acquire new hematology analyzers are leaning out a few years in their plans.

Click here to view a larger version of this chart.

Sysmex leads under systems in use with Beckman Coulter well represented.

Satisfaction with hematology analyzers has remained high for several years. Nine out of 10 labs assign their hematology instrumentation the highest ratings.

Click here to view a larger version of this chart.

Sysmex leads among vendors under consideration with Beckman Coulter following. Others, including CellaVision, Siemens Healthineers, and Roche also are in the mix.